GT Biopharma
GTBP
GTBP
49 hedge funds and large institutions have $69.7M invested in GT Biopharma in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.62% more ownership
Funds ownership: 0.09% → 0.71% (+0.62%)
Holders
49
Holding in Top 10
–
Calls
$9K
Puts
–
Top Buyers
| 1 | +$21.9M | |
| 2 | +$11.1M | |
| 3 | +$7.91M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.81M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.35M |
Top Sellers
| 1 | -$320K | |
| 2 | -$191K | |
| 3 | -$156K | |
| 4 |
Squarepoint
New York
|
-$113K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$16K |